Detalhe da pesquisa
1.
Bile exosomal miR-182/183-5p increases cholangiocarcinoma stemness and progression by targeting HPGD and increasing PGE2 generation.
Hepatology;
79(2): 307-322, 2024 Feb 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37140231
2.
PTPN9 dephosphorylates FGFR2 pY656/657 through interaction with ACAP1 and ameliorates pemigatinib effect in cholangiocarcinoma.
Hepatology;
79(4): 798-812, 2024 Apr 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37505213
3.
Function of mast cell and bile-cholangiocarcinoma interplay in cholangiocarcinoma microenvironment.
Gut;
2024 Mar 08.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38458750
4.
SMAD4 regulates the progression of cholangiocarcinoma by modulating the expression of STING1.
J Cell Mol Med;
27(17): 2547-2561, 2023 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37488750
5.
PTP-MEG2 regulates quantal size and fusion pore opening through two distinct structural bases and substrates.
EMBO Rep;
22(5): e52141, 2021 05 05.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33764618
6.
BMI1 promotes cholangiocarcinoma progression and correlates with antitumor immunity in an exosome-dependent manner.
Cell Mol Life Sci;
79(9): 469, 2022 Aug 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35932322
7.
CD74+ macrophages are associated with favorable prognosis and immune contexture in hepatocellular carcinoma.
Cancer Immunol Immunother;
71(1): 57-69, 2022 Jan.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34009409
8.
WDR5 facilitates EMT and metastasis of CCA by increasing HIF-1α accumulation in Myc-dependent and independent pathways.
Mol Ther;
29(6): 2134-2150, 2021 06 02.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33601056
9.
Identification and structure-function analyses of an allosteric inhibitor of the tyrosine phosphatase PTPN22.
J Biol Chem;
294(21): 8653-8663, 2019 05 24.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30979725
10.
Computational Strategy for Bound State Structure Prediction in Structure-Based Virtual Screening: A Case Study of Protein Tyrosine Phosphatase Receptor Type O Inhibitors.
J Chem Inf Model;
58(11): 2331-2342, 2018 11 26.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30299094
11.
TBL1XR1 predicts isolated tumor cells and micrometastasis in patients with TNM stage I/II colorectal cancer.
J Gastroenterol Hepatol;
32(9): 1570-1580, 2017 Sep.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28127799
12.
Identification of a benzo imidazole thiazole derivative as the specific irreversible inhibitor of protein tyrosine phosphatase.
Bioorg Med Chem Lett;
26(19): 4795-4798, 2016 10 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-27554446
13.
Protein Flexibility in Docking-Based Virtual Screening: Discovery of Novel Lymphoid-Specific Tyrosine Phosphatase Inhibitors Using Multiple Crystal Structures.
J Chem Inf Model;
55(9): 1973-83, 2015 Sep 28.
Artigo
em Inglês
| MEDLINE
| ID: mdl-26360643
14.
Molecular mechanism of ERK dephosphorylation by striatal-enriched protein tyrosine phosphatase.
J Neurochem;
128(2): 315-329, 2014 Jan.
Artigo
em Inglês
| MEDLINE
| ID: mdl-24117863
15.
Case report: Obstructive jaundice caused by biliary cystadenoma.
Front Oncol;
13: 1165979, 2023.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37064112
16.
Effects of o-cresol on the growth and biochemical compositions in marine microalgae.
Mar Environ Res;
191: 106164, 2023 Oct.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37713779
17.
Triboelectric Nanogenerators Based on Super-Stretchable Conductive Hydrogels with the Assistance of Deep-Learning for Handwriting Recognition.
ACS Appl Mater Interfaces;
15(27): 32993-33002, 2023 Jul 12.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37381708
18.
Discovery of benzofuran-2-carboxylic acid derivatives as lymphoid tyrosine phosphatase (LYP) inhibitors for cancer immunotherapy.
Eur J Med Chem;
258: 115599, 2023 Oct 05.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37399712
19.
Budd-Chiari syndrome and its associated hepatocellular carcinoma: Clinical risk factors and potential immunotherapeutic benefit analysis.
Front Oncol;
12: 1075685, 2022.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36568193
20.
Wnt-TCF7-SOX9 axis promotes cholangiocarcinoma proliferation and pemigatinib resistance in a FGF7-FGFR2 autocrine pathway.
Oncogene;
41(20): 2885-2896, 2022 05.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35428876